Research Summary
Erectile dysfunction drugs, also known as ED medications or phosphodiesterase type 5 (PDE5) inhibitors, are prescription or over-the-counter medications used to treat erectile dysfunction, a condition characterized by difficulty achieving or sustaining an erection suitable for sexual intercourse. Common ED drugs include sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra), among others. These medications work by relaxing the smooth muscle tissue in the blood vessels of the penis, increasing blood flow to the area and facilitating an erection in response to sexual stimulation. They are typically taken orally and are effective for a set duration, typically several hours, allowing men to engage in sexual activity during that time. ED drugs have revolutionized the treatment of erectile dysfunction, providing many individuals with an effective and reliable solution to improve their sexual health and quality of life. However, they should be used under the guidance of a healthcare professional, as they may have potential side effects or interactions with other medications.
According to DIResearch's in-depth investigation and research, the global Erectile Dysfunction Drugs market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Erectile Dysfunction Drugs include Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, CSBIO, Seoul Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Erectile Dysfunction Drugs. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Erectile Dysfunction Drugs market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Erectile Dysfunction Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Erectile Dysfunction Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Erectile Dysfunction Drugs Include:
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
CSBIO
Seoul Pharma
Erectile Dysfunction Drugs Product Segment Include:
Sildenafil
Tadalafil
Others
Erectile Dysfunction Drugs Product Application Include:
Hospital Pharmacies
Private Clinics
Retail Pharmacies
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Erectile Dysfunction Drugs Industry PESTEL Analysis
Chapter 3: Global Erectile Dysfunction Drugs Industry Porter's Five Forces Analysis
Chapter 4: Global Erectile Dysfunction Drugs Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Erectile Dysfunction Drugs Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Erectile Dysfunction Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Erectile Dysfunction Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Erectile Dysfunction Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Erectile Dysfunction Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Erectile Dysfunction Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Erectile Dysfunction Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Erectile Dysfunction Drugs Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Erectile Dysfunction Drugs Market Overview 1.1 Product Definition and Statistical Scope 1.2 Erectile Dysfunction Drugs Product by Type 1.2.1 Global Erectile Dysfunction Drugs Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Sildenafil 1.2.3 Tadalafil 1.2.4 Others 1.3 Erectile Dysfunction Drugs Product by Application 1.3.1 Global Erectile Dysfunction Drugs Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Hospital Pharmacies 1.3.3 Private Clinics 1.3.4 Retail Pharmacies 1.4 Global Erectile Dysfunction Drugs Market Revenue and Sales Analysis 1.4.1 Global Erectile Dysfunction Drugs Market Size Analysis (2019-2030) 1.4.2 Global Erectile Dysfunction Drugs Market Sales Analysis (2019-2030) 1.4.3 Global Erectile Dysfunction Drugs Market Sales Price Trend Analysis (2019-2030) 1.5 Erectile Dysfunction Drugs Market Development Status and Trends 1.5.1 Erectile Dysfunction Drugs Industry Development Status Analysis 1.5.2 Erectile Dysfunction Drugs Industry Development Trends Analysis 2 Erectile Dysfunction Drugs Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Erectile Dysfunction Drugs Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Erectile Dysfunction Drugs Market Analysis by Regions 4.1 Erectile Dysfunction Drugs Overall Market: 2023 VS 2024 VS 2030 4.2 Global Erectile Dysfunction Drugs Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Erectile Dysfunction Drugs Revenue and Market Share by Region (2019-2024) 4.2.2 Global Erectile Dysfunction Drugs Revenue Forecast by Region (2025-2030) 4.3 Global Erectile Dysfunction Drugs Sales and Forecast Analysis (2019-2030) 4.3.1 Global Erectile Dysfunction Drugs Sales and Market Share by Region (2019-2024) 4.3.2 Global Erectile Dysfunction Drugs Sales Forecast by Region (2025-2030) 4.4 Global Erectile Dysfunction Drugs Sales Price Trend Analysis (2019-2030) 5 Global Erectile Dysfunction Drugs Market Size by Type and Application 5.1 Global Erectile Dysfunction Drugs Market Size by Type 5.1.1 Global Erectile Dysfunction Drugs Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Erectile Dysfunction Drugs Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Erectile Dysfunction Drugs Market Size by Application 5.2.1 Global Erectile Dysfunction Drugs Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Erectile Dysfunction Drugs Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Erectile Dysfunction Drugs Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Erectile Dysfunction Drugs Market Size by Type 6.3.1 North America Erectile Dysfunction Drugs Sales by Type (2019-2030) 6.3.2 North America Erectile Dysfunction Drugs Revenue by Type (2019-2030) 6.4 North America Erectile Dysfunction Drugs Market Size by Application 6.4.1 North America Erectile Dysfunction Drugs Sales by Application (2019-2030) 6.4.2 North America Erectile Dysfunction Drugs Revenue by Application (2019-2030) 6.5 North America Erectile Dysfunction Drugs Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Erectile Dysfunction Drugs Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Erectile Dysfunction Drugs Market Size by Type 7.3.1 Europe Erectile Dysfunction Drugs Sales by Type (2019-2030) 7.3.2 Europe Erectile Dysfunction Drugs Revenue by Type (2019-2030) 7.4 Europe Erectile Dysfunction Drugs Market Size by Application 7.4.1 Europe Erectile Dysfunction Drugs Sales by Application (2019-2030) 7.4.2 ? Europe Erectile Dysfunction Drugs Revenue by Application (2019-2030) 7.5 Europe Erectile Dysfunction Drugs Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Erectile Dysfunction Drugs Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Erectile Dysfunction Drugs Market Size by Type 8.3.1 China Erectile Dysfunction Drugs Sales by Type (2019-2030) 8.3.2 China Erectile Dysfunction Drugs Revenue by Type (2019-2030) 8.4 China Erectile Dysfunction Drugs Market Size by Application 8.4.1 China Erectile Dysfunction Drugs Sales by Application (2019-2030) 8.4.2 China Erectile Dysfunction Drugs Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Erectile Dysfunction Drugs Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Erectile Dysfunction Drugs Market Size by Type 9.3.1 APAC (excl. China) Erectile Dysfunction Drugs Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Erectile Dysfunction Drugs Revenue by Type (2019-2030) 9.4 APAC (excl. China) Erectile Dysfunction Drugs Market Size by Application 9.4.1 APAC (excl. China) Erectile Dysfunction Drugs Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Erectile Dysfunction Drugs Revenue by Application (2019-2030) 9.5 APAC (excl. China) Erectile Dysfunction Drugs Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Erectile Dysfunction Drugs Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Erectile Dysfunction Drugs Market Size by Type 10.3.1 Latin America Erectile Dysfunction Drugs Sales by Type (2019-2030) 10.3.2 Latin America Erectile Dysfunction Drugs Revenue by Type (2019-2030) 10.4 Latin America Erectile Dysfunction Drugs Market Size by Application 10.4.1 Latin America Erectile Dysfunction Drugs Sales by Application (2019-2030) 10.4.2 Latin America Erectile Dysfunction Drugs Revenue by Application (2019-2030) 10.5 Latin America Erectile Dysfunction Drugs Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Erectile Dysfunction Drugs Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Erectile Dysfunction Drugs Market Size by Type 11.3.1 Middle East & Africa Erectile Dysfunction Drugs Sales by Type (2019-2030) 11.3.2 Middle East & Africa Erectile Dysfunction Drugs Revenue by Type (2019-2030) 11.4 Middle East & Africa Erectile Dysfunction Drugs Market Size by Application 11.4.1 Middle East & Africa Erectile Dysfunction Drugs Sales by Application (2019-2030) 11.4.2 Middle East & Africa Erectile Dysfunction Drugs Revenue by Application (2019-2030) 11.5 Middle East & Africa Erectile Dysfunction Drugs Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Erectile Dysfunction Drugs Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Erectile Dysfunction Drugs Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Erectile Dysfunction Drugs Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Erectile Dysfunction Drugs Average Sales Price by Manufacturers (2020-2024) 12.2 Erectile Dysfunction Drugs Competitive Landscape Analysis and Market Dynamic 12.2.1 Erectile Dysfunction Drugs Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Eli Lilly 13.1.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Eli Lilly Erectile Dysfunction Drugs Product Portfolio 13.1.3 Eli Lilly Erectile Dysfunction Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Pfizer 13.2.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Pfizer Erectile Dysfunction Drugs Product Portfolio 13.2.3 Pfizer Erectile Dysfunction Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 Bayer 13.3.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Bayer Erectile Dysfunction Drugs Product Portfolio 13.3.3 Bayer Erectile Dysfunction Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 BaiYunShan General Factory 13.4.1 BaiYunShan General Factory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 BaiYunShan General Factory Erectile Dysfunction Drugs Product Portfolio 13.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 S.K. Chemicals 13.5.1 S.K. Chemicals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 S.K. Chemicals Erectile Dysfunction Drugs Product Portfolio 13.5.3 S.K. Chemicals Erectile Dysfunction Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.6 Teva Pharma 13.6.1 Teva Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Teva Pharma Erectile Dysfunction Drugs Product Portfolio 13.6.3 Teva Pharma Erectile Dysfunction Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.7 Dong-A ST 13.7.1 Dong-A ST Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Dong-A ST Erectile Dysfunction Drugs Product Portfolio 13.7.3 Dong-A ST Erectile Dysfunction Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.8 Metuchen Pharma 13.8.1 Metuchen Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Metuchen Pharma Erectile Dysfunction Drugs Product Portfolio 13.8.3 Metuchen Pharma Erectile Dysfunction Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.9 CSBIO 13.9.1 CSBIO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 CSBIO Erectile Dysfunction Drugs Product Portfolio 13.9.3 CSBIO Erectile Dysfunction Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.10 Seoul Pharma 13.10.1 Seoul Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Seoul Pharma Erectile Dysfunction Drugs Product Portfolio 13.10.3 Seoul Pharma Erectile Dysfunction Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Erectile Dysfunction Drugs Industry Chain Analysis 14.2 Erectile Dysfunction Drugs Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Erectile Dysfunction Drugs Typical Downstream Customers 14.4 Erectile Dysfunction Drugs Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support